Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS
NCT00844844Phase 2Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- May 2009
- Primary completion
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of eculizumab in atypical hemolytic uremic syndrome (aHUS), sponsored by Alexion Pharmaceuticals. Started May 2009; status: completed.
02
Drugs
eculizumab
03
Conditions
atypical hemolytic uremic syndrome (aHUS)
Beyond the preview
Go deeper on NCT00844844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00844844.